neostigmine has been researched along with Heart Disease, Ischemic in 2 studies
Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sun, KO | 1 |
| Botero, C | 1 |
| Smith, CE | 1 |
| Morscher, AH | 1 |
2 other studies available for neostigmine and Heart Disease, Ischemic
| Article | Year |
|---|---|
Bronchospasm after esmolol and neostigmine.
Topics: Adrenergic beta-Antagonists; Appendectomy; Bronchial Spasm; Humans; Intraoperative Complications; Ma | 1993 |
Anemia and perioperative myocardial ischemia in a Jehovah's Witness patient.
Topics: Adrenergic beta-Antagonists; Anemia; Anesthetics, Inhalation; Cholinesterase Inhibitors; Christianit | 1996 |